If you have been reading about prothymosin alpha and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Hong Kong is a major stop-over for foreign fish maw to be smuggled into mainland China, in order to circumvent food-safety import laws and import duties to mainland China. In Kenya, fish maw fished from Lake Victoria is smuggled through to Uganda and Tanzania to avoid export duties to China, as China charges a GDP-dependent duty on imports.
Cocaine, heroin, cannabis, and other such drugs continued to be legally available without prescription as long as they were labeled. It is estimated that sale of patent medicines containing opiates decreased by 33% after labeling was mandated. In 1906 in Britain and in 1908 in Canada "laws requiring disclosure of ingredients and limitation of narcotic content were instituted". The Harrison Narcotics Tax Act of 1914 restricted the manufacture and distribution of opiates, including laudanum, and coca derivatives in the US. This was followed by France's Loi des stupéfiants in 1916, and Britain's Dangerous Drugs Act in 1920. Laudanum was supplied to druggists and physicians in regular and concentrated versions. For example, in 1915, Frank S. Betz Co., a medical supply company in Hammond, Indiana, advertised Tincture of Opium, U.S.P., for $2.90 per lb., Tincture of Opium Camphorated, U.S.P, for 85 cents per lb., and Tincture of Opium Deodorized, for $2.85 per lb. Four versions of opium as a fluid extract were also offered: (1) Opium, Concentrated (assayed) "For making Tincture Opii (Laudanum) U.S.P. Four times the strength of the regular U.S.P." tincture, for $9.35 per pint; (2) Opium, Camphorated Conc. "1 oz. making 8 ozs. Tr. Opii Camphorated U.S.P (Paregoric)" for $2.00 per pint; (3) Opium, Concentrated (Deodorized and Denarcotized) "Four times the strength of tincture, Used when Tinct. Opii U.S.P. is contraindicated" for $9.50 per pint, and (4) Opium (Aqueous), U.S.P., 1890, "Tr. (assayed) Papaver Somniferum" for $2.25 per pint.
During the recording of A Loner, Chanut used an old Marshall JMP head to add more upper mids, giving the sound a more defined character. To get a "really fat sound" in the studio, he used his Rivera electric guitar amplifier, the brand's first generation. For the electric guitar parts, the band wanted a "bright sound" with less gain and "to remove this flattering aspect" of the sub-bass characteristic of doom or sludge metal. To "let the music breathe more" and to highlight the guitar effects, particularly the reverbs, Thépegnier decided to "lighten" his drumming. Thépegnier further stated that they wanted to "lighten" their sound and achieve this "bright" result that would enable them to embrace "our cold ambiences even more. Getting out of our 'doomy' comfort zone". Journalist Jean-Charles Desgroux wrote that the band "dares to experiment" on A Loner and "beyond doom, sludge or at worst that muddy stoner which they will never claim". David wrote in his review of A Loner: "The French group experiments, plays with effects, textures and nuances". At this stage of their musical evolution, they demonstrated a greater presence of melodies and introspection and were sometimes more atmospheric. While Hangman's Chair blended various doom sounds to create an atmosphere on This Is Not Supposed To Be Positive, they sounded, on A Loner, like a different band from their earlier work, with gothic sounds closer to goth rock and cold wave than metal at this stage. The "stoner band" they had been in the past had nevertheless left some "artefacts" in their music.
The Inca roads traversed difficult terrain, rising to great heights and incorporating stairways to overcome steep inclines. As the Incas lacked wheels and horses, travel was on foot or with llamas, and rest stops provided food and shelter along the routes. The Spanish, finding these roads unsuitable for their horses, often dismantled them for building materials. However, in remote areas, sections of the original roads survived. At 4,374 yards (4,000 m) in Assuay (now Páramo de Azuay), Humboldt examined the ruins of the palace of Inca Tupac Yupanqui, including a site he believed to be an observatory. Humboldt also encountered descendants of the Inca nobility, including a young man who maintained a belief in the restoration of the Inca Empire and recounted legends of a hidden golden garden beneath the ruins. The descendant expressed reluctance to seek the treasure, citing a resigned awareness that any gold discovered would be seized by outsiders. Through these observations and encounters, Humboldt documented the enduring presence of Inca culture and the legacy of pre-Columbian civilizations in Peru.
While the presence of ethyl carbamate is not a sensory wine fault, the compound is a suspected carcinogen which is subjected to regulation in many countries. The compound is produced from the degradation of the amino acid arginine which is present in both grape must and released in the wine through the autolysis of dead yeast cells. While the use of urea as a source of yeast assimilable nitrogen (no longer legal in most countries) was the most common cause of ethyl carbamate in wine, both O. oeni and L. buchneri have been known to produce carbamyl phosphate and citrulline which can be precursors to ethyl carbamate formation. L. hilgardii, one of the "ferocious Lactobacillus" species, has also been suspected of contributing to ethyl carbamate production. In the United States, the Alcohol and Tobacco Tax and Trade Bureau has established a voluntary target limit of ethyl carbamate in wine to less than 15 μg/L for table wines and less than 60 μg/L for dessert wines. Biogenic amines have been implicated as a potential cause of red wine headaches. In wine, histamine, cadaverine, phenylethylamine, putrescine, and tyramine have all been detected. These amines are created by the degradation of amino acids found in grape must and left over from the breakdown of dead yeast cells after fermentation. Most LAB have the potential to create biogenic amines, even some strains of O. oeni, but high levels of biogenic amines are most often associated with species from the Lactobacillus and Pediococcus genera.
Sources: en.wikipedia.org
=== Carcinogenesis === Deregulation of CK1δ contributes to tumorigenesis and tumor progression through deregulation of Wnt/β-catenin-, p53-, Hedgehog-, and Hippo-related signaling. CK1δ mRNA is overexpressed in various cancer entities, among them bladder cancer, brain cancer, breast cancer, colorectal cancer, kidney cancer, lung adenocarcinoma, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, hematopoietic malignancies and lymphoid neoplasms. Also decreased CK1δ mRNA expression levels have been observed in some cancer studies, like urinary bladder cancer, lung squamous cell carcinoma, stomach cancer, kidney cancer, esophageal cancer as well as head and neck cancer. Besides those, reduced CK1δ activity owing to the site N172D mutation of CK1δ decelerated mammary carcinoma progression, and prolonged mouse survival in a transgenic mouse model. The two CK1δ mutations, R324H and T67S identified in intestinal mucosa and in a colorectal tumor, respectively, exhibit increased carcinogenic potential.
7α-Acetylthio-17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone 7α-Acetylthio-3-oxo-17α-pregn-4-ene-21,17β-carbolactone 3-(3-Oxo-7α-acetylthio-17β-hydroxyandrost-4-en-17α-yl)propionic acid lactone 7α-Acetylthio-17α-(2-carboxyethyl)androst-4-en-17β-ol-3-one γ-lactone 7α-Acetylthio-17α-(2-carboxyethyl)testosterone γ-lactone
=== 23 May === In its evening report, the Ukrainian military reported that there were 25 air strikes and 20 incidents of shelling reported across the country for the day, but no missile attacks. Yevgeny Prigozhin, head of the Wagner Group, promised to transfer control of the Ukrainian city of Bakhmut to the Russian army by 1 June. In an interview, he said that more than 20,000 of his fighters died in the battle for the city, and acknowledged that the Russian military had killed civilians. President Zelenskyy visited naval infantry troops along the Vuhledar-Maryinka defence line in Donetsk Oblast as part of commemorations of the Day of the Ukrainian Marines. He announced that new marine brigades would be added to the Ukrainian military's existing units. The governor of Donetsk Oblast said Russian aerial bombs struck Toretsk, damaging a school but causing no casualties. The Russian Ministry of Defence said that it had forced back "nationalists" who had launched the cross-border attacks in Belgorod Oblast back into Ukraine, adding that its forces had killed more than 70 "Ukrainian terrorists" and destroyed four armored combat vehicles and five pickups. The Governor of Russia's Kursk Oblast said three villages bordering Ukraine were left without power after a drone dropped explosives on an electrical substation. Ukraine accused Russia of blocking access to the port of Pivdennyi to grain exports despite the resumption of the Black Sea Grain Initiative.
A poultice or cataplasm, also called a fomentation, is a soft moist mass, often heated and medicated, that is applied to the skin to reduce inflammation, soothe pain, promote healing, or otherwise treat wounds or ailments. Soft materials like cereals serve as a base for agents intended to affect the body transdermally. The preparation is usually spread on cloth, which is then applied to the area being treated. The cloth is used to keep the preparation in place, or additional bandaging to hold the poultice may be employed. Direct topical application (without cloths) is also used. The term "poultice" may also refer to a porous solid, filled with a solvent, and used to remove stains from porous stone such as marble or granite.
Sources: en.wikipedia.org
=== Food === The plant is the source of several popular herbs and one spice used in a wide variety of recipes, particularly among Mediterranean cuisines. They are typically removed from dishes before serving, although they may also be used as a simple garnish. Whole bay leaves have a long shelf life of about one year, under normal temperature and humidity. Whole bay leaves are used almost exclusively as flavor agents during the food preparation stage. Ground bay leaves, however, can be ingested safely and are often used in soups and stocks, as well as being a common addition to a Bloody Mary. Dried laurel berries and pressed leaf oil can both be used as robust spices, and the wood can be burnt for strong smoke flavoring.
== See also == Aneutronic fusion Cold fusion Fusion power Neutrino astronomy Nuclear fusion Proton–proton chain, as found in stars like the Sun Stellar nucleosynthesis, the whole topic Triple-alpha process, how 12C is produced from lighter nuclei
Russ Prize "for automating DNA sequencing that revolutionized biomedicine and forensic science"; the 2011 National Medal of Science, presented at a White House ceremony by President Obama in early 2013; the IEEE Medal for Innovations in Healthcare Technology in 2014, and the 2016 Ellis Island Medal of Honor. In 2017 he received the NAS Award for Chemistry in Service to Society. In 2019 Hood was awarded the IRI Medal, established by the Industrial Research Institute (IRI).
=== Animal health === One meta-analysis published in 2003 suggested a negative impact of rBST's effects on bovine health. Findings suggested an average increase in milk output ranging from 11–16%, an approximate 24% increase in the risk of clinical mastitis, a 40% reduction in fertility, and 55% increased risk of developing clinical signs of lameness. The same study reported a decrease in body condition score for cows treated with rBST, though an increase in their dry matter intake occurred. Another meta-analysis (2003) reported on body condition scores (BCS) but could not reach a conclusion due to lack of homogeneity in study design and reporting. They found a trend towards decreased BCS in treated cows but state "Depending on the level of body condition in these cows, this effect may have been beneficial or detrimental." This analysis did not report on clinical mastitis. A more recent meta-analysis (2014) published by the Journal of the American Veterinary Medical Association showed no significant increase in risk of clinical mastitis nor other adverse effects on cow health and well-being. This review included 26 peer-reviewed studies that involved the use of the rBST-Zn formulation available to US producers in accordance with the label instructions for treatment initiation (57 to 70 days after birth), dose (500 mg, every 14 days), and route (subcutaneous). Mastitis has cost American dairy industries an estimated $1.5 to 2 billion per year in treating dairy cows.
=== Flavoring agents === A large number of pyridine compounds are approved as flavoring agents in the EU. These include the three isomeric picolines and several lutidines. Selected representatives are listed in the following table.
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.